Expert commentary
Critical Thinking, Current Issues, and Collective Perspectives
Global Metabolic & Liver Health Policy
Global Metabolic & Liver Health Policy
01/08/2025
01/08/2025
Author: Naim Alkhouri
Annual exams should focus on identifying at‑risk MASH, where intervention can change outcomes.
Global Metabolic & Liver Health Policy
Global Metabolic & Liver Health Policy
22/07/2025
22/07/2025
Author: Jeff Lazarus
Recent expert commentary and the flagship event of the Global Think-Tank signal a long-overdue policy reckoning for chronic liver disease.
Public Health & Clinical Best Practices
Public Health & Clinical Best Practices
15/06/2025
15/06/2025
Author: Jörn M Schattenberg
Millions of people with type 2 diabetes are silently developing advanced liver disease—and many care teams don’t even know it. The good news is that identifying risk doesn’t have to add complexity.
Metabolic & Liver Health Equity
Metabolic & Liver Health Equity
29/05/2025
29/05/2025
Author: Jeff Lazarus
At a recent community event, I met a New Yorker whose story left me a bit unsettled. She told me how her husband had passed away from something called MASH — metabolic dysfunction-associated steatohepatitis.
















































